Supernus Pharmaceuticals (SUPN) EV to EBIT (2015 - 2025)
Supernus Pharmaceuticals' (SUPN) EV to EBIT stood at 19.43 in Q2 2025, down 54.1% from 42.37 a year earlier but up 5.8% from the prior quarter.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) EV to EBIT (2015 - 2025) Analysis & Trends
On a TTM basis, Supernus Pharmaceuticals' EV to EBIT came in at -1.16 as of Jun 30, 2025; for FY2024, it came in at 19.13.
- Across earlier years, EV to EBIT came in at 31.96 in FY2022 (+126.6%), 14.10 in FY2021 (+169.9%) and 5.23 in FY2020 (-13.6%).
- Quarterly EV to EBIT has ranged from 4.35 in Q3 2020 to 78.88 in Q3 2022 over the past five years.
- Peak year-over-year performance for EV to EBIT in the last five years was growth of 903.6% in Q3 2022, against a decline of 54.1% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 18.37 (Q1 2025), 19.13 (Q4 2024) and 22.25 (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Supernus Pharmaceuticals | 2.59 Bn | 1.25 Bn | 185.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 19.43 |
| Mar 31, 2025 | 18.37 |
| Dec 31, 2024 | 19.13 |
| Sep 30, 2024 | 22.25 |
| Jun 30, 2024 | 42.37 |
| Sep 30, 2023 | 43.10 |
| Jun 30, 2023 | 72.51 |
| Mar 31, 2023 | 35.21 |
| Dec 31, 2022 | 31.96 |
| Sep 30, 2022 | 78.88 |
| Jun 30, 2022 | 22.67 |
| Mar 31, 2022 | 18.84 |
| Dec 31, 2021 | 14.10 |
| Sep 30, 2021 | 7.86 |
| Jun 30, 2021 | 8.32 |
| Mar 31, 2021 | 6.29 |
| Dec 31, 2020 | 5.23 |
| Sep 30, 2020 | 4.35 |
| Jun 30, 2020 | 5.64 |
| Mar 31, 2020 | 3.58 |
API Access
Supernus Pharmaceuticals EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();